Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-07-10
The filing discloses entry into a Second Amendment to a Member Interest and Asset Exchange Agreement dated July 7, 2026, whereby TLSS will acquire an 80% membership interest in Patriot Glass Solutions, LLC and four nanotechnology patents in exchange for $4.75 million in Series J Preferred Stock. This is a material acquisition transaction with a defined purchase price, closing conditions, and expected closing by August 4, 2026, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting M&A activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-10
The filing discloses entry into a material definitive agreement (Item 1.01) whereby XMax Inc.'s subsidiary Xmax Beta Holdings Ltd. made an additional subscription of US$8,770,000 in Preamble X Capital I, increasing its ownership interest to more than 99.9%. Item 2.01 confirms completion of this acquisition of assets. The substantial capital commitment and near-total ownership stake constitute material M&A activity, though the exact nature of the underlying investment vehicle warrants some caution on confidence.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Jones Soda issued 7.5 million units at $0.33 per unit for $2.5 million in aggregate gross proceeds, with each unit comprising one common share and one-half warrant. The filing explicitly discloses this under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), and the units were sold to accredited investors under Rule 506(b) and to non-U.S. persons under Regulation S—classic private placement mechanics. The company also announced a concurrent non-brokered offering of up to 2.3 million additional units for $765,000. This is a dilutive equity issuance raising capital through unregistered securities.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-10
The filing discloses new employment agreements for three named executives (CEO Ryan Melsert, CFO Alejandro Flores Arteaga, and COO Steven Wu) effective July 1, 2026, specifying annual salaries, performance-based bonuses, RSU grants, and stock option awards. The Compensation Committee approved these arrangements under Section 16b-3. This is a classic executive compensation disclosure under Item 5.02(e), distinct from appointment or departure since these executives are continuing in their existing roles under revised compensation terms.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-10
The filing discloses multiple capital allocation events: (1) a one-time cash dividend of $0.05 per share (~$1 million aggregate) approved by the Board and payable August 3, 2026; (2) a share repurchase program authorizing up to 10 million shares or 50% of outstanding shares with $20 million allocated through July 2027; and (3) a preliminary balance sheet update following the EMJX acquisition and reverse split. While the filing contains multiple material events, the primary Item 7.01 disclosure centers on the dividend announcement, supported by the repurchase program and balance sheet update. The dividend is material to investors as a direct return of capital from SpaceX investment profits.
View raw filing on EDGAR →
6-K
Exec departure
confidence 85%
filed 2026-07-10
Mr. Harry Tang is stepping down from his role as Chief Technology Officer effective July 30, 2026, to become a senior advisor. Although he remains with the company in a different capacity, the principal disclosed action is a departure from an executive officer position (CTO). The filing explicitly states the change was for personal reasons and involved no disagreement with the company, consistent with a voluntary transition rather than a removal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-10
The filing discloses results of SKYX Platforms Corp.'s 2026 Annual Meeting of Stockholders held on July 8, 2026, under Item 5.07. The company reports voting outcomes for three matters: election of seven directors (Rani R. Kohen, Nancy DiMattia, Gary N. Golden, Efrat L. Greenstein Brayer, Thomas J. Ridge, Dov Shiff, and Leonard J. Sokolow), ratification of M&K CPAS, PLLC as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies for each matter are provided, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-07-10
EX-99.6
This exhibit is Form 45-106F1, a Canadian "Report of Exempt Distribution" template used to disclose private placements and exempt offerings of securities. The form's structure and instructions indicate it is filed to report distributions of securities (shares, notes, warrants, etc.) made under exemptions from prospectus requirements in Canadian securities law. While the exhibit shown is the blank form template rather than a completed report with specific transaction details, its presence as an exhibit to a 6-K filing by Avricore Health indicates the company has conducted or is reporting an exempt distribution—a dilutive issuance of equity or debt securities outside registered public offerings. This is material to investors as it affects share dilution and capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-10
Item 7.01
The filing announces Origin Bancorp's plan to issue second quarter 2026 financial results on July 22, 2026, and host a conference call on July 23, 2026, to discuss those results. The press release explicitly states "Origin Bancorp, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call" and identifies the executives who will discuss the results. This is a standard earnings release announcement, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-10
Item 8.01
The filing discloses preliminary assets under management (AUM) as of June 30, 2026, totaling $183.4 billion, along with a breakdown by investment strategy. While AUM reporting is routine for asset managers, the disclosure includes a material operational development: the termination of a U.S. sub-advisory mandate resulting in approximately $5.7 billion in net outflows from the Value Equity strategy, with an orderly wind-down of the U.S. Value team's strategies expected to continue through Q3. This operational restructuring affecting a significant portion of managed assets qualifies as material to investors assessing the firm's business trajectory.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-07-10
Item 1.01
Nu-Med Plus completed the acquisition of Avid Gold Ltd and its subsidiary Maritimes Gold Corp on July 8, 2026, issuing 4,500,000 Series A Exchange Shares to Avid Gold shareholders, and entered into a Mineral Property Purchase Agreement to acquire six gold properties spanning over 30,900 acres in Atlantic Canada from MegumaGold Corp. This material acquisition represents a significant diversification of the company's business from medical devices into gold exploration and development operations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-10
Item 1.01
The Warrant Amendment materially reduces the exercise price from $16.00 to $1.50 per share for a 30-day period, creating a significant dilutive incentive for the investor to exercise and acquire common stock at a substantially discounted price. This amendment to an existing warrant arrangement effectively facilitates a dilutive equity issuance, as the reduced exercise price makes exercise highly attractive and increases the likelihood of share dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-10
Item 5.02
The disclosure centers on the appointment of Matt Levine as Chief Legal Officer effective July 27, 2026, with detailed background on his prior roles at Clear Secure and Success Academy. While Erin Abrams's departure is also mentioned, the principal action disclosed is the appointment of a new CLO to fill this officer-level position. The appointment of a C-suite executive is material to investors assessing the company's leadership and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-10
Item 5.07
Veritone held its Annual Meeting of Stockholders on July 7, 2026, with shareholders voting on six proposals: election of directors (Steelberg and Morales), ratification of CBIZ CPAs P.C. as auditor, advisory vote on executive compensation, amendment to Certificate of Incorporation to increase authorized Common Stock shares from 150 million to 225 million, amendment to the 2023 Equity Incentive Plan to increase authorized shares by 3,000,000, and approval of executive RSU awards.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-10
Item 5.02
The Board authorized and stockholders approved an amendment to the Veritone 2023 Equity Incentive Plan increasing authorized shares by 3,000,000 for equity compensation purposes, expanding the company's capacity to grant equity awards to executives and employees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-10
Item 5.02
The filing discloses the appointment of Joshua Chien as an independent director of the Board, effective July 8, 2026, upon recommendation from the Nominating and Corporate Governance Committee. While the Item 5.02 section also mentions compensatory arrangements (annual cash retainer of $60,000 and restricted share unit award of $170,000), the principal disclosed action is the appointment of a director to the Board. This is material as it affects the composition and governance of the company's leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-10
Item 2.02
Occidental Petroleum disclosed a summary of "earnings considerations" for Q2 2026 under Item 2.02, providing specific operational metrics including average diluted shares outstanding (1,012.2 million), cash flow impacts from crude oil collar settlements ($156 million negative), and detailed realized prices for oil, NGL, and natural gas across regions. While labeled as preliminary and not a comprehensive earnings estimate, this constitutes a pre-earnings disclosure of material financial and operational results for the quarter, consistent with the earnings_release classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-10
Item 5.02
The filing discloses the appointment of two independent directors, Vivek Mohindra and Eiso Kant, to the Board of Directors of Axon Enterprise effective July 8, 2026, along with their committee assignments. While the disclosure also includes compensatory arrangements (RSU awards and cash retainers), the principal disclosed action centers on the appointment of these individuals to the Board and their committee roles, making exec_appointment the most salient classification. The material nature is clear given the addition of senior leadership to the Board.
View raw filing on EDGAR →
8-K
Legal Other
confidence 72%
filed 2026-07-10
Item 8.01
The disclosure centers on management's investigation and allegations of market manipulation and improper trading in Cycurion's stock, including evidence of spoofing, short-sale circuit breaker violations, and abnormal trading volumes (89.9M shares traded against 86.5M float in October 2025; 45% intraday collapse in March 2026). Management states it is "in contact with NASDAQ" and intends to "pursue those parties responsible for improper trading and market manipulation." While the letter also discusses business performance and the decision to decline a reverse split, the substantive disclosure focuses on the company's forensic review findings and stated intention to pursue legal/regulatory remedies for suspected market abuse—a legal/regulatory matter material to investors assessing trading integrity and potential enforcement outcomes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-10
Item 5.02
Jerome Lorrain resigned as Executive Chairman on July 10, 2026, which is the principal disclosed action. Although the filing also discloses his continued service as a non-employee director and amendments to his equity awards, the core event is his departure from the Executive Chairman role. The material impact stems from the loss of executive leadership and the forfeiture of performance-based equity awards tied to that position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-10
This disclosure announces positive Phase III clinical trial results (ARTEMIS-008) for risvutatug rezetecan (Ris-Rez), a B7-H3-targeted antibody-drug conjugate, demonstrating statistically significant overall survival improvements in advanced/relapsed small-cell lung cancer. While the announcement concerns a clinical development milestone rather than a discrete corporate event (M&A, executive change, financial obligation, or accounting matter), it represents a material operational/strategic development affecting GSK's oncology pipeline and regulatory prospects. The positive Phase III data, regulatory designations (Breakthrough Therapy, Orphan Drug, PRIME), and advancement of the global development program constitute material information affecting investor assessment of GSK's product portfolio and future commercial potential.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 88%
filed 2026-07-10
Item 3.02
Ocean Thermal Energy Corp. authorized and issued Series E Preferred Stock, a convertible security, to raise capital. Two shares were sold to private investors for $20,000 in aggregate under Section 4(a)(2) and Regulation D exemptions, with authorization for up to 150 shares totaling $1.5 million. The preferred shares are convertible into common stock upon specified triggering events, materially diluting existing shareholders' ownership.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-10
Item 5.02
The filing discloses Board-approved amendments to the Employment Agreements of the CEO and CFO, including material changes to both cash compensation (base salary increase from $31,000 to $37,800 monthly for Mr. Iglesias, two-month performance bonus, and bonus timing flexibility) and equity compensation (replacement of annual equity incentives with Series B Preferred Share grants subject to shareholder approval). This is a classic Item 5.02(e) compensatory arrangement disclosure affecting named executives.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-10
Item 5.02
Mark Oswald, Executive Vice President and Chief Financial Officer, provided notice on July 6, 2026 of his intention to leave his position no later than December 31, 2026. The disclosure centers on the departure of a named executive officer from a material C-suite role (CFO), with no indication of a replacement appointment yet made. The company has only initiated an external search, confirming this is a departure event rather than an appointment.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-10
EX-99.1
This is a notification of a relevant change to a significant shareholder under AIM Rules. BlackRock, Inc. crossed a notification threshold on July 8, 2026, increasing its voting rights from 6.15% to 6.17% (1,193,783 voting rights total, comprising 5.25% direct shares, 0.55% via securities lending, and 0.36% via CFDs). While this is a governance disclosure concerning shareholder composition and voting rights, it does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results. The disclosure is material because it reports a significant shareholder's crossing of a regulatory notification threshold, which affects the total mix of information about the registrant's ownership structure and control.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-10
Item 8.01
The disclosure reports a material asset liquidation event: sale of 1,400 BTC for ~$87.1 million in gross proceeds since May 7, 2026, with proceeds allocated to debt repayment ($10 million), funding a property acquisition, and covering litigation expenses. While this is a significant financial transaction affecting the company's treasury position and capital allocation, it does not fit neatly into the specific financial event categories (debt_issuance, dividend_distribution, material_impairment, etc.). The event is clearly financial in nature and material to investors assessing the company's liquidity and strategic positioning, making financial_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-10
Item 5.02
Thomas J. DeRosa was released from his roles as President and Chief Executive Officer effective immediately on July 1, 2026. While the filing also discloses the appointment of Felipe A. Corrado IV as Interim CEO, the principal disclosed action centers on the departure of the sitting CEO. The removal of a chief executive officer is material to investors' assessment of the registrant's leadership and governance.
View raw filing on EDGAR →
8-K
Legal Other
confidence 75%
filed 2026-07-10
Item 1.01
The filing discloses entry into a Release Agreement settling a dispute with the former president of a wholly-owned subsidiary, with the Company agreeing to pay CAD$1,500,000 (approximately US$1.06 million). While Item 1.01 typically covers M&A activity, this is a settlement agreement resolving a dispute rather than an acquisition, merger, or change of control. The event is material due to the significant cash outlay and resolution of a dispute with a former executive, but it is fundamentally a legal settlement rather than a transaction in the M&A sense, making legal_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-10
Item 5.02
Robert Jackson, a Director of Kinetic Seas Inc., resigned from all positions effective July 8, 2026, citing pursuit of other business ventures and conflict-of-interest concerns. This is a clear executive departure — the principal disclosed action is a director leaving the company. Director resignations are material to investors as they affect board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-10
Item 8.01
This Item 8.01 disclosure reports the final voting results from T Stamp Inc.'s deferred 2025 Annual Meeting of Stockholders held on July 7, 2026. The filing presents detailed vote tallies for all four proposals, including director elections (David Curmi and Berta Pappenheim), auditor ratification (CBIZ CPAs), and approval of warrant issuance under Nasdaq Rule 5635(d). All proposals were approved. This is a classic shareholder_vote_results disclosure under Item 5.07 standards, reported here under Item 8.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Item 3.02
The filing discloses an unregistered sale of 9,232,047 shares of common stock pursuant to a Securities Purchase Agreement with C/M Capital Master Fund, LP, generating $1,265,063 in gross proceeds. The transaction was conducted under Section 4(a)(2) and Rule 506(b) exemptions, with the purchaser's resales subsequently registered on Form S-1. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-07-10
Item 2.03
On July 8–10, 2026, Nuveen Churchill Direct Lending Corp. entered into an underwriting agreement and issued $100.0 million in aggregate principal amount of 6.650% Notes due March 15, 2030, bringing total outstanding 2030 Notes to $400 million. The notes are unsecured direct obligations of the Company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-10
Item 3.02
Origin Materials issued one share of Series A Junior Preferred Stock to General Counsel Joshua Lee for $0.01 per share in an unregistered transaction. The issuance represents a material capital structure change, particularly given the Company's prior announcement of a Plan of Dissolution, and the preferred stock carries liquidation preferences senior to common stock.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-10
Item 3.03
The Company issued Series A Junior Preferred Stock with material modifications to security holder voting rights and preferences, including a new class of preferred stock with special voting rights tied to dissolution meetings and a formula-based voting mechanism granting the holder votes equal to outstanding Common Stock.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-10
Item 5.02
Five directors—John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou—are stepping down from the Board effective July 31, 2026, in connection with the Company's planned Dissolution, representing a substantial change in governance structure and signaling the company's imminent wind-down.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-10
Item 5.07
This Item 5.07 filing discloses the results of an Annual Meeting of stockholders where three proposals were voted on: election of five directors, ratification of Deloitte & Touche LLP as independent auditor, and approval of a reverse stock split amendment. The filing presents detailed voting tallies for each proposal, confirming all three passed. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition, auditor appointment, and authorization for a significant corporate action (reverse split).
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-10
EX-99.1
Micware announces the launch of a new subsidiary (Micware Spacia Co., Ltd.) through renaming a consolidated subsidiary and reorganizing its business structure. The DynaPlanet platform transfers from Micware to Micware Spacia, with Masahide Shigeno assuming CEO of the new entity while retaining his CTO role at Micware. This is a material operational and strategic restructuring that reflects Micware's growth strategy pivot toward spatial intelligence and platform business operations, effective September 1, 2026. While not a discrete M&A transaction, the reorganization is a significant strategic business event affecting the registrant's operational structure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-10
This 6-K discloses the results of K Wave Media Ltd.'s 2026 annual general meeting held on July 10, 2026, with voting outcomes on seven proposals including director appointments, a share consolidation (up to 30:1 ratio), authorized share capital increase, name change, amended articles of association, and termination of a share purchase agreement. The disclosure of shareholder vote results on material corporate actions—particularly the share consolidation and name change—is material to investors' assessment of the company's capital structure and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-10
EX-99.1
The press release announces the appointment of Carl von Halem as Interim Chief Financial Officer of VERAXA Biotech AG, succeeding Torsten Bürgermeister. While the disclosure also references Bürgermeister's departure, the principal disclosed action is the appointment of a named executive to a C-suite role. The appointment of a CFO is material to investors as it affects the company's financial leadership and operational continuity, particularly given the company's recent NASDAQ listing and growth phase.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-10
Item 8.01
This disclosure concerns a SPAC's extension of its business combination deadline through a $60,000 deposit into the trust account, extending the period from July 10, 2026 to August 10, 2026. While the event involves a financial deposit, the core substance is a governance/structural matter affecting the company's timeline and shareholder rights — a material event for SPAC investors assessing the likelihood and timing of a business combination.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-07-10
Item 1.01
Vivakor entered into an amendment to a debt satisfaction agreement with the CEO involving reinstatement of preferred stock dividends and issuance of dividend shares in exchange for extinguishment of $500,000 in debt owed to the CEO. The transaction affects capital structure and obligations through a combination of debt relief and dividend distribution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Item 3.02
Vivakor issued 3,740,586 shares of restricted common stock to Series A Preferred Stock holders as a dividend payment, including 1,445,349 shares to entities controlled by the CEO. The unregistered issuance is exempt under Section 4(a)(2) and materially dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-10
Item 6.02
This disclosure reports the removal of CWCAM as special servicer and appointment of Rialto Capital Advisors, LLC (RCA) as successor special servicer effective July 10, 2026, pursuant to Section 6.05(a) of the pooling and servicing agreement. While the filing is technically Item 6.02 (Change of Servicer or Trustee), the event is fundamentally a governance/administrative change in the trust's service provider structure. The disclosure is material because it affects the administration and servicing of approximately $15.48 billion in unpaid principal balance of specially serviced loans and REO properties, which would impact certificateholders' interests in the trust.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-10
Item 5.02
While Dr. Anderson's retirement was previously disclosed (April 10, 2026), the principal new disclosure here is the consulting agreement entered into on July 6, 2026, which establishes compensatory arrangements including hourly fees ($216/hour for up to 10 hours/week), continued vesting of restricted stock awards, and conditional equity acceleration (25% automatic vesting upon completion of the full term). This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category under Item 5.02(e), though the departure itself was already known.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-10
Item 2.02
Ategrity announced preliminary Q2 2026 financial results exceeding guidance and analyst expectations, including record gross written premiums of $205M+ (22% YoY growth), combined ratio below 87%, and record diluted EPS of $0.60+ versus $0.47 consensus.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-10
Item 5.02
Neil Adler was appointed as Chief Financial Officer effective July 9, 2026, with an annual base salary of $200,000. The appointment follows the non-renewal of the employment agreement of departing CFO Neelam Patel, effective September 16, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-09
Item 8.01
MSA Safety announced completion of the acquisition of Autronica Fire and Security for approximately $555 million. The press release explicitly states "MSA Safety Incorporated...today announced that it has completed the acquisition of Autronica Fire and Security in a transaction valued at approximately $555 million." This is a material acquisition that expands MSA's fixed detection business into a $3 billion-plus addressable market and is expected to be accretive to adjusted earnings per share in the first full year of ownership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-09
Item 2.02
This is a clear earnings release disclosing PepsiCo's second-quarter and year-to-date 2026 financial results. The Item 2.02 filing includes a press release dated July 9, 2026, reporting net revenue of $24.181 billion (Q2) and $43.624 billion (YTD), with detailed operating profit, EPS, and segment performance metrics. The filing also includes condensed consolidated financial statements and updated 2026 guidance, which are material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
The filing discloses the appointment of three officers to SoCalGas: Karen L. Sedgwick as CEO and President (effective Q3 2026), Ross W. Turrini as Chief Operating Officer (effective August 10, 2026), and Elvia Lima Ortiz as Vice President, Chief Accounting Officer and Controller (effective July 10, 2026). While the section also includes a departure (Sara P. Mijares resigning as Chief Accounting Officer) and compensation details for the new appointees, the principal disclosed actions center on the three executive appointments, particularly the CEO appointment, which is material to investors assessing leadership and strategic direction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-09
Item 2.02
WD-40 Company issued a news release on July 9, 2026, disclosing financial results for the third fiscal quarter ended May 31, 2026. The release reports net sales of $195.1 million (24% increase), operating income of $40.3 million (47% increase), and diluted EPS of $2.24 (45% increase), along with updated fiscal year 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →